Security key
874060205
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)
CUSIP: 874060205
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 82,262,152
- Total 13F value
- $1,355,589,943
- Share change
- +15,075,394
- Put/Call ratio
- 28%
- SEC-reported price per share
- $16.48
- Number of holders
- 296
- Value change
- +$248,962,456
- Number of buys
- 149
- Number of sells
- 86
Open additional details 1 more signal available
Report period
Q1 2023
Institutions
296
Top holders
10
TAK full security history
Ownership snapshot
Full 13F holder table
TAKEDA PHARMACEUTICAL CO LTD SEC filings
TAKEDA PHARMACEUTICAL CO LTD company facts
TAKEDA PHARMACEUTICAL CO LTD 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F
Highest disclosed value: $70,565,659
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY has the largest disclosed position value at $70.57M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Disclosed position value
Top 5
MORGAN STANLEY
$70.57M
Mondrian Investment Partners LTD
$69.88M
Clal Insurance Enterprises Holdin...
$68.1M
GOLDMAN SACHS GROUP INC
$61.69M
ARROWSTREET CAPITAL, LIMITED PART...
$60.91M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$70,565,659
4,523,439 shares
|
— | 31 Dec 2022 |
| Mondrian Investment Partners LTD |
13F
Company
|
—
class O/S missing
|
$69,883,000
4,367,715 shares
|
— | 31 Dec 2022 |
| Clal Insurance Enterprises Holdings Ltd |
13F
Company
|
—
class O/S missing
|
$68,102,000
4,365,500 shares
|
— | 31 Dec 2022 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
class O/S missing
|
$61,690,262
3,954,504 shares
|
— | 31 Dec 2022 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
Company
|
—
class O/S missing
|
$60,907,000
3,904,296 shares
|
— | 31 Dec 2022 |
| MACQUARIE GROUP LTD |
13F
Company
|
—
class O/S missing
|
$59,841,054
3,835,990 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
296
Shares
82,262,152
Rows available
296
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
296
Q1 2023 holders
296
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|